Diagnosis and treatment of non-Hodgkin's lymphoma in the elderly;Diagnostiek en behandeling van het non-Hodgkin-lymfoom bij de oudere patient

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 45, 1997, Pages 2152-2157

  Doorduijn, J K ^a   Sonneveld, P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

AGED; AGING; CANCER SURVIVAL; DRUG TOXICITY; HUMAN; NONHODGKIN LYMPHOMA; PALLIATIVE THERAPY; PROGNOSIS; QUALITY OF LIFE; SHORT SURVEY;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; PALLIATIVE CARE; PROGNOSIS; QUALITY OF LIFE;

EID: 0030660623     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (29)

1. Visser O, Coebergh JWW, Schouten LJ. Incidence of cancer in the Netherlands, 1993 Fifth report of the Netherlands cancer registry. Utrecht: Vereniging Integrale Kankercentra, 1996.
2. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas summary and description of a working formulation for clinical usage. The Non-hodgkin's lymphoma pathologic classification project. Cancer 1982;49:2112-35.
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
4. Jong D de, Kluin PhM. Nieuwe lymfoomclassificatie: een stap vooruit voor pathologen en clinici. Ned Tijdschr Geneeskd 1997;141: 1601-13.
5. Carbone A, Volpe R, Gloghini A, Trovo M, Zagonel V, Tirelli U, et al. Non-Hodgkin's lymphoma in the elderly. I. Pathologic features at presentation. Cancer 1990;66:1991-4.
6. Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977;61:1023-7.
7. A predictive model for aggressive non-Hodgkin's lymphoma. The International non-hodgkin's lymphoma prognostic factors project. N Engl J Med 1993;329:987-94.
8. Portlock CS. Management of the low-grade non-Hodgkin's lymphomas. Semin Oncol 1990;17:51-9.
9. Hochster HS, Kim KM, Green MD, Mann RB, Neiman RS, Oken MM, et al. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. J Clin Oncol 1992;10:28-32.
10. Hagenbeek A, Carde P, Somers R, Thomas J, Bock R de, Hoof A van, et al. Interferon-alfa-2a vs control as maintenance therapy for low-grade non-Hodgkin's lymphoma: results from a prospective randomized clinical trial. Proc Annu Meet Am Soc Clin Oncol 1995,14. A1203.
11. Lopez-Guillermo A, Montserrat E, Bosch F, Terol MJ, Campo E, Rozman C. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol 1994; 12:1343-8.
12. Denham JW, Denham E, Dear KB, Hudson GV. The follicular non-Hodgkin's lymphomas - I. The possibility of cure. Eur J Cancer 1996:32A:470-9.
13. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkins lymphoma. N Engl J Med 1993;328:1002-6.
14. Dixon DO, Neilan B, Jones SE, Lipschitz DA, Miller TP, Grozea PN, et al Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol 1986:4 295-305
15. Solal-Celigny P, Chastang C, Herrera A, Desaint B, Renoux M, Gaulard P, et al. Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma. Am J Med 1987;83:1075-9.
16. Tirelli U, Zagonel V, Serraino D, Thomas J, Hoerni B, Tangury A, et al. Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group study. J Clin Oncol 1988;6: 1708-13.
17. Vose JM, Armitage JO, Weisenburger DD, Bierman PJ. Sorensen S, Hutchins M, et al. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma J Clin Oncol 1988;6:1838-44.
18. Mead GM, Macbeth FR, Williams CJ, Ryall RDH, Wright DH, Whitehouse JMA. Poor prognosis non-Hodgkin's lymphoma in the elderly: clinical presentation and management. Q J Med 1984;53. 381-90.
19. Tirelli U, Carbone A, Zagonel V, Veronesi A, Canetta R. Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients. Eur J Cancer Clin Oncol 1987;23:535-40.
20. Meyer RM, Browman GP, Samosh ML, Benger AM, Bryant-Lukosius D, Wilson WE, et al. Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma. J Clin Oncol 1995;13:2386-93
21. O'Reilly SE, Klimo P, Connors JM. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. J Clin Oncol 1991;9:741-7.
22. Tirelli U, Zagonel V, Errante D, Serraino D, Talamini R, De Cicco M, et al. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma. J Clin Oncol 1992;10:228-36.
23. Sonneveld P, Ridder M de, Lelie H van der, Nieuwenhuis K, Schouten H, Mulder A, et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol 1995;13:2530-9.
24. Hryniuk WM. The importance of dose intensity in the outcome of chemotherapy. In: Hellman S, DeVita V, Rosenberg S, editors. Important advances in oncology Philadelphia Lippincott, 1988:121-41
25. Coebergh JWW. Significant trends in cancer in the elderly. Eur J Cancer 1996;32A:569-71.
26. Rijke JM de, Schouten LJ, Schouten HC, Jager JJ, Koppejan AG, Brandt PA van den Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands. Ann Oncol 1996;7:677-85.
27. Haak HL, Kluin PM, Meyer CJLM, Otter R, Stijnen T, Bieger R, et al Population-based registration of non-Hodgkin lymphoma in the region covered by the Comprehensive Cancer Centre West. Neth J Med 1986;29:105-10.
28. Fentiman IS, Tirelli U, Monfardini S, Schneider M, Festen J, Cognetti F, et al Cancer in the elderly: why so badly treated? Lancet 1990;335:1020-2.
29. McKenna sr RJ. Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up. Cancer 1994;74(7 Suppl):2107-17.